American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. O'Reilly
    O'Reilly
  4. Saltz
    Saltz
  5. Bajorin
    Bajorin
  6. Kris
    Kris
  7. Hudis
    Hudis
  8. Morris
    Morris
  9. Rosenberg
    Rosenberg
  10. Robson
    Robson

Groups

  1. Department of Medicine (6399)
  2. Solid Tumor Oncology Division (5537)
  3. Survivorship Research (1997)
  4. Genitourinary Oncology Service (1768)
  5. Surgery (1637)
  6. Epidemiology and Biostatistics (1495)
  7. GSK Faculty (1389)
  8. Population Sciences Research Program (1379)
  9. Gastrointestinal Oncology Service (1353)
  10. Hematologic Malignancies, Division of (1281)
Search Within
Formats
  1. Meeting Abstract (6334)
  2. Journal Article (2579)
  3. Editorial (76)
  4. Review (68)
  5. Guidelines (54)
  6. Correspondence (49)
  7. Miscellaneous (4)
  8. Conference Paper (3)
Groups
  1. Department of Medicine (6399)
  2. Solid Tumor Oncology Division (5537)
  3. Survivorship Research (1997)
  4. Genitourinary Oncology Service (1768)
  5. Surgery (1637)
  6. Epidemiology and Biostatistics (1495)

More Groups

People
  1. Robert Motzer (451)
  2. Howard Scher (334)
  3. Eileen O'Reilly (306)
  4. Leonard Saltz (283)
  5. Dean Bajorin (280)
  6. Mark Kris (253)

More People

Years
  1. 2025 (275)
  2. 2024 (554)
  3. 2023 (580)
  4. 2022 (554)
  5. 2021 (504)
  6. 2020 (539)

More Years

Publications
  1. Journal of Clinical Oncology (8694)
  2. JCO Precision Oncology (171)
  3. Journal of Oncology Practice (124)
  4. American Society of Clinical Oncology Educational Book (112)
  5. JCO Clinical Cancer Informatics (53)
  6. JCO Oncology Practice (7)

More Publications

Results (9167)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • NF1-driven rhabdomyosarcoma phenotypes: A comparative clinical and molecular study of NF1-mutant rhabdomyosarcoma and NF1-associated malignant triton tumor
    Journal Article

    de Traux de Wardin, H.; Dermawan, J. K.; Vanoli, F.; Jiang, S. C.; Singer, S.; Chi, P.; Tap, W.; Wexler, L. H.; Antonescu, C. R.
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Prognostic implications of small cell lung cancer transcriptional subtyping for CNS metastases
    Journal Article

    Tringale, K. R.; Skakodub, A.; Egger, J.; Eichholz, J.; Yu, Y.; Gomez, D.; Rimner, A.; Li, B.; Yamada, Y.; Wilcox, J.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Natural history and genomic landscape of chemotherapy-resistant muscle-invasive bladder cancer
    Journal Article

    Lenis, A. T.; Whiting, K.; Ravichandran, V.; Tallman, J. E.; Alam, S. M.; Chu, C. E.; De Jesus Escano, M.; Bochner, E.; Katims, A.; Reisz, P. A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Phase II study of osimertinib in patients with epidermal growth factor receptor mutations: Results from the NCI-MATCH ECOG-ACRIN (EAY131) trial subprotocol E
    Journal Article

    Chen, M. F.; Song, Z.; Yu, H. A.; Sequist, L. V.; Lovly, C. M.; Mitchell, E. P.; Moscow, J. A.; Gray, R. J.; Wang, V.; McShane, L. M.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Evaluation of real-world tumor response derived from electronic health record data sources: A feasibility analysis in patients with metastatic non-small cell lung cancer treated with chemotherapy
    Journal Article

    McKelvey, B. A.; Garrett-Mayer, E.; Rivera, D. R.; Alabaster, A.; Andrews, H. S.; Bond, E. G.; Brown, T. D.; Bruno, A.; Damato, L.; Espirito, J. L.; more...
    JCO Clinical Cancer Informatics (2024)

    Fulltext@MSK | Save
  • Cureit: An end-to-end pipeline for implementing mixture cure models with an application to liposarcoma data
    Journal Article

    Whiting, K.; Fei, T.; Singer, S.; Qin, L. X.
    JCO Clinical Cancer Informatics (2024)

    Fulltext@MSK | Save
  • Clinical calculator for predicting freedom from recurrence after resection of stage I-III colon cancer in patients with microsatellite instability
    Journal Article

    Bektas, A. B.; Hakki, L.; Khan, A.; Widmar, M.; Wei, I. H.; Pappou, E.; Smith, J. J.; Nash, G. M.; Paty, P. B.; Garcia-Aguilar, J.; more...
    JCO Clinical Cancer Informatics (2024)

    Fulltext@MSK | Save
  • Phase I and randomized phase II study of ruxolitinib with frontline neoadjuvant therapy in advanced ovarian cancer: An NRG Oncology Group Study
    Journal Article

    Landen, C. N.; Buckanovich, R. J.; Sill, M. W.; Mannel, R. S.; Walker, J. L.; Disilvestro, P. A.; Mathews, C. A.; Mutch, D. G.; Hernandez, M. L.; Martin, L. P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Extrahepatic cholangiocarcinoma: Genomic variables associated with anatomic location and outcome
    Journal Article

    Preston, W. A.; Drill, E.; Boerner, T.; Gelfer, R.; Harding, J. J.; O'Reilly, E. M.; Cercek, A.; Abou-Alfa, G.; Park, W.; Balachandran, V. P.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Phase II, single-arm trial of induction and concurrent vismodegib with curative-intent radiation therapy for locally advanced, unresectable basal cell carcinoma
    Journal Article

    Barker, C. A.; Dufault, S.; Arron, S. T.; Ho, A. L.; Algazi, A. P.; Dunn, L. A.; Humphries, A. A.; Hultman, C.; Lian, M.; Knott, P. D.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save